Skip to main content
. 2019 Dec 16;21(1):108–116. doi: 10.3348/kjr.2019.0215

Table 7. Diagnostic Performance of Simulated Biopsy Criteria in KTA/KSThR, ATA, and ACR Guidelines.

Simulated Biopsy Criteria Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%) Unnecessary FNA Rate (%)
Criteria 1
 KTA/KSThR* 94.5/100 26.4/28.0 27.4/22.4 94.2/100 41.9/40.4 56.9/59.6
 ATA* 93.8/99.0 27.9/28.0 27.7/22.3 93.9/99.3 42.9/40.3 55.7/59.6
 ACR 93.4/96.0 37.3/37.1 30.4/24.1 95.1/97.8 50.1/47.3 48.5/52.0
Criteria 2
 KTA/KSThR 90.5/97.0 43.3/43.9 31.9/26.5 94.0/98.6 54.1/53.1 43.8/46.4
 ATA 90.5/97.0 41.7/40.4 31.3/25.3 93.8/98.5 52.8/50.2 45.1/49.3
 ACR 90.3/94.1 48.4/48.9 34.0/27.7 94.5/97.5 58.0/56.7 39.9/42.3
Criteria 3
 KTA/KSThR 76.9/85.1 55.2/57.9 33.5/29.7 89.0/94.9 60.1/62.6 34.7/34.8
 ATA 78.9/86.1 53.2/53.4 33.1/27.8 89.5/94.9 59.0/59.0 36.2/38.6
 ACR 75.6/80.2 61.4/63.9 36.5/31.6 89.5/93.9 64.7/66.7 29.8/29.9
Criteria 4
 KTA/KSThR 75.6/85.1 63.7/66.4 37.9/34.5 89.9/95.5 66.4/69.6 28.1/27.8
 ATA 77.5/86.1 62.2/62.7 37.6/32.5 90.4/95.6 65.7/66.7 29.2/30.9
 ACR* 74.7/80.2 67.3/68.9 40.2/34.9 90.1/94.4 69.0/70.8 25.3/25.8

Data are diagnostic values of dataset 1 (n = 2000)/diagnostic values of dataset 2 (n = 586). *Original biopsy size criteria of each guideline. FNA = fine-needle aspiration, NPV = negative predictive value, PPV = positive predictive value